{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T19:11:54Z","timestamp":1776366714966,"version":"3.51.2"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2012,5,3]],"date-time":"2012-05-03T00:00:00Z","timestamp":1336003200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0036284","type":"journal-article","created":{"date-parts":[[2012,5,3]],"date-time":"2012-05-03T21:05:54Z","timestamp":1336079154000},"page":"e36284","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":69,"title":["Heart Rate and Use of Beta-Blockers in Stable Outpatients with Coronary Artery Disease"],"prefix":"10.1371","volume":"7","clinical-trial-number":[{"clinical-trial-number":"isrctn43070564","registry":"10.18810\/isrctn"}],"author":[{"given":"Ph. Gabriel","family":"Steg","sequence":"first","affiliation":[]},{"given":"Roberto","family":"Ferrari","sequence":"additional","affiliation":[]},{"given":"Ian","family":"Ford","sequence":"additional","affiliation":[]},{"given":"Nicola","family":"Greenlaw","sequence":"additional","affiliation":[]},{"given":"Jean-Claude","family":"Tardif","sequence":"additional","affiliation":[]},{"given":"Michal","family":"Tendera","sequence":"additional","affiliation":[]},{"given":"H\u00e9l\u00e8ne","family":"Abergel","sequence":"additional","affiliation":[]},{"given":"Kim M.","family":"Fox","sequence":"additional","affiliation":[]},{"name":"for the CLARIFY Investigators","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2012,5,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(96)07493-4","article-title":"Mortality by cause for eight regions of the world: Global Burden of Disease Study.","volume":"349","author":"CJ Murray","year":"1997","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMp068182","article-title":"Expanding priorities\u2013confronting chronic disease in countries with low income.","volume":"356","author":"GF Anderson","year":"2007","journal-title":"N Engl J Med"},{"issue":"suppl D","key":"ref3","doi-asserted-by":"crossref","first-page":"D13","DOI":"10.1093\/eurheartj\/sup017","article-title":"Heart rate management in coronary artery disease: the CLARIFY registry.","volume":"11","author":"PG Steg","year":"2009","journal-title":"Eur Heart J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/eurheartj\/ehi190","article-title":"Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease.","volume":"26","author":"A Diaz","year":"2005","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0002-9149(90)91029-6","article-title":"Influence of heart rate on mortality after acute myocardial infarction.","volume":"65","author":"A Hjalmarson","year":"1990","journal-title":"Am J Cardiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/eurheartj\/ehn123","article-title":"Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR\/trandolapril STudy (INVEST).","volume":"29","author":"R Kolloch","year":"2008","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jacc.2007.04.079","article-title":"Resting heart rate in cardiovascular disease.","volume":"50","author":"K Fox","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(08)61171-X","article-title":"Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial.","volume":"372","author":"K Fox","year":"2008","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(10)61259-7","article-title":"Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.","volume":"376","author":"M Bohm","year":"2010","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"b219","DOI":"10.1136\/bmj.b219","article-title":"Resting heart rate as a low tech predictor of coronary events in women: prospective cohort study.","volume":"338","author":"J Hsia","year":"2009","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","article-title":"beta Blockade after myocardial infarction: systematic review and meta regression analysis.","volume":"318","author":"N Freemantle","year":"1999","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/eurheartj\/ehn571","article-title":"Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.","volume":"30","author":"JC Tardif","year":"2009","journal-title":"Eur Heart J"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.CIR.0000048143.25023.87","article-title":"Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial.","volume":"107","author":"JS Borer","year":"2003","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/eurheartj\/ehi586","article-title":"Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.","volume":"26","author":"JC Tardif","year":"2005","journal-title":"Eur Heart J"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","article-title":"Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.","volume":"372","author":"K Fox","year":"2008","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1093\/eurheartj\/ehp358","article-title":"Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.","volume":"30","author":"K Fox","year":"2009","journal-title":"Eur Heart J"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","article-title":"Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.","volume":"372","author":"K Fox","year":"2008","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/eurheartj\/ehr293","article-title":"Relationship between discharge heart rate and mortality in patients after acute myocardial infarction treated with primary percutaneous coronary intervention.","volume":"33","author":"ML Antoni","year":"2012","journal-title":"Eur Heart J"},{"key":"ref19","first-page":"A12667","article-title":"Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET\/TRANSCEND.","volume":"122","author":"S Rambihar","year":"2010","journal-title":"Circulation"},{"issue":"Abstract Suppl","key":"ref20","first-page":"801","article-title":"Heart rate as a predictor of cardiovascular risk in coronary heart disease patients with diabetes.","volume":"31","author":"DD Waters","year":"2010","journal-title":"Eur Heart J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.amjcard.2009.11.035","article-title":"Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial).","volume":"105","author":"JE Ho","year":"2010","journal-title":"Am J Cardiol"},{"key":"ref22","first-page":"2092","article-title":"ACC\/AHA\/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina).","volume":"33","author":"RJ Gibbons","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/pgmj.2009.084384","article-title":"Inadequate control of heart rate in patients with stable angina: results from the European heart survey.","volume":"86","author":"CA Daly","year":"2010","journal-title":"Postgrad Med J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/eurheartj\/ehl001","article-title":"Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology.","volume":"27","author":"K Fox","year":"2006","journal-title":"Eur Heart J"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/j.jacc.2007.08.002","article-title":"2007 chronic angina focused update of the ACC\/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina.","volume":"50","author":"TD Fraker Jr","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ejheart.2008.08.005","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).","volume":"10","author":"K Dickstein","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/CIRCOUTCOMES.109.919415","article-title":"Optimal medical therapy for non-ST-segment-elevation acute coronary syndromes: exploring why physicians do not prescribe evidence-based treatment and why patients discontinue medications after discharge.","volume":"3","author":"AJ Bagnall","year":"2010","journal-title":"Circulation Cardiovascular quality and outcomes"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1001\/jama.281.20.1927","article-title":"Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.","volume":"281","author":"PA Heidenreich","year":"1999","journal-title":"JAMA"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/archinte.167.1.68","article-title":"External validity of clinical trials in acute myocardial infarction.","volume":"167","author":"PG Steg","year":"2007","journal-title":"Arch Intern Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(04)17670-8","article-title":"External validity of randomised controlled trials: \u201cto whom do the results of this trial apply?\u201d.","volume":"365","author":"PM Rothwell","year":"2005","journal-title":"Lancet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0033-0620(76)90012-8","article-title":"Circulatory adjustments to dynamic exercise and effect of physical training in normal subjects and in patients with coronary artery disease.","volume":"18","author":"JP Clausen","year":"1976","journal-title":"Prog Cardiovasc Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0036284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T04:38:56Z","timestamp":1713933536000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0036284"}},"subtitle":[],"editor":[{"given":"Adrian V.","family":"Hernandez","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2012,5,3]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0036284","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,3]]}}}